When was Rytary approved by the FDA?

Written by Ana de Barros, PhD |

A

When was Rytary approved by the FDA?

Category: Rytary

The U.S. Food and Drug Administration approved Rytary in 2015 for the treatment of people with Parkinson’s disease, which may include patients with early, moderate, and advanced disease. The regulatory agency also approved the medication for certain kinds of parkinsonism, or conditions with Parkinson’s-like symptoms.

Ana de Barros, PhD avatar

About the Author

Ana de Barros, PhD Ana holds a PhD in immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. Ana was awarded two FCT fellowships and has won the Portuguese Immunology Society Best Paper and Best Poster award in 2009 and 2010, as well as the CESPU International Research Award in 2010. After leaving the lab to pursue a career in science communication, she served as the director of science communication at iMM Lisbon.